Zhejiang Shengda Bio-Pharm Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 169.28 million compared to CNY 185.17 million a year ago. Revenue was CNY 169.28 million compared to CNY 185.17 million a year ago.

Net income was CNY 3.49 million compared to CNY 20.8 million a year ago. Basic earnings per share from continuing operations was CNY 0.02 compared to CNY 0.12 a year ago. Diluted earnings per share from continuing operations was CNY 0.02 compared to CNY 0.12 a year ago.